Wondering what’s new in NF research? The NF research community is sharing their knowledge with the world. Check out the following events.

October 6th – December 10th, 2021

INFER (International NF Educational Resources) is a series of online educational lectures for medical professionals by leading neurofibromatosis experts. Children’s Tumor Foundation will be offering the following masterclasses:

• Oct 6: NF1 Cutaneous Neurofibromas
• Oct 25: NF1 Malignant Peripheral Nerve Sheath Tumors
• Nov 9: NF1 Orthopedic Manifestations
• Dec 10: NF1 Associated Glioma in Children – the Optic Pathway and Beyond

November 10th, 2021, 2:00 PM EST

Dr. Ratner’s will present “Addressing NF1 Loss in Oligodendrocytes.” Her research interests include glial cell biology, intracellular signaling, preclinical therapeutics, and peripheral nerve tumorigenesis. Dr. Ratner and her team share the goal of finding innovative treatments for neurofibromatosis by utilizing their knowledge of developmental biology together and levels of ribonucleic acid (RNA) and proteins in neurofibroma tumor and immune cell types as guides for drug selection and testing.

Some of the notable discoveries made by Dr. Ratner and her team include: 1) developing and producing transcriptome data for investigating NF1 cells and nerve tumors and 2) pioneering the use of mitogen-activated protein kinase (MEK) inhibitors in a new and original preclinical model of the peripheral nerve tumor. This research led clinicians to pursue clinical trials, and in 2020, the Food and Drug Administration (FDA) granted approval for use of MEK inhibitors as a therapy for plexiform neurofibromas.

Meeting Details:

Join from PC, Mac, Linux, iOS or Android, Meeting ID: 995 7047 2518

Or iPhone one-tap :+16468769923,,99570472518#
Or Telephone: +1 646 876 9923
Or internally by extension: 3-MEET (36338)

International numbers available: https://rock-meet.zoom.us/u/aciPks4crT